FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump celebrates after UN climate committee moves away from its most extreme global warming scenario

Trump scores major Republican primary victory as Cassidy ousted in Louisiana

Maduro’s alleged ‘bag man’ Alex Saab arrested less than 3 years after Biden pardon: report

Massachusetts governor asks US Navy to help retrieve bodies, evidence from sunken fishing vessel

Trump shares stunning photos of Lincoln Memorial Reflecting Pool renovation, says project is ahead of schedule

Suspected drunk driver kills 2 pedestrians in violent chain-reaction crash on Manhattan’s Upper West Side

Breaking: US Makes ‘Intense Preparations’ for Impending Iran Attacks as Trump Sends Warning

US Attorney Pirro Lays Down Law: Parents Need to Stop ‘Teen Takeovers’ or Face Jail

We Were Right: 13 Heads Roll as DC Police’s Conspiracy to Deceive Public on Astronomical Crime Rates Exposed

Pope Leo does ‘6-7’ trend for children at the Vatican

Violent Repeat Offender Left Psych Ward Days Before Allegedly Shooting Up Busy Massachusetts Street

Second FDA executive departing organization in less than a week as top drug regulator claims she was fired

Largest children’s hospital in US to open ‘detransition clinic’ after $10M settlement with Trump DOJ, state

Major Thermos Product Recalled After Causing Vision Loss in Three People

ActBlue CEO faces June 10 grilling after fundraising powerhouse allegedly misled Congress on foreign donations

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”